✦ LIBER ✦

PINI6 COST-UTILITY OF CHRONIC HEPATITIS “C” TREATMENT WITH THYMOSIN ALPHA I IN MEXICO

✍ Scribed by A Nevarez-Sida; F Garcia-Contreras; P Constantino-Casas; A Castro-Rios; J Mould; J Garduno-Espinosa

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost-effectiveness of Chronic Hepatitis

✍ Fernando García-Contreras; Armando Nevárez-Sida; Patricia Constantino-Casas; Fer 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 426 KB

PGI8 COST-EFFECTIVENESS OF PEG-IFN ALPHA

✍ G Salinas Escudero; J Idrovo; R Rivas; J Ramirez Rodriguez; IA Rico Alba; L Zapa 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB

PGI3 COST-EFFECTIVENESS OF PEG-IFN ALPHA

✍ Salinas Escudero, G; Idrovo, J; Rivas, R; Ramirez Rodriguez, J; Rico Alba, IA; Z 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 66 KB

PGI25 Cost-Utility Analysis of Telaprevi

✍ M. Lukac; J. Bielik; J. Holoman; D. Tomek; A. Suvadova; T. Foltanova; V. Foltan 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 61 KB

PIN18 COST-UTILITY ANALYSIS OF TREATMENT

✍ X Sun; Y Li; L Zhao 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

Cost effectiveness and cost utility anal

✍ Soto, H.; Pizarro, M.; Botello, B.S.; Almeida, E. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB